Trial intelligence / Profile preview

Total Thyroidectomy vs Thionamides in Moderate-to-Severe Graves' Ophthalmopathy

NCT03066076Phase 3Unknown

Sponsor
Medical University of Vienna
Start
Mar 2017
Primary completion
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of methimazole, propylthiouracil in Graves' ophthalmopathy (TED), Graves' disease, sponsored by Medical University of Vienna. Status: unknown.

02

Drugs

methimazolepropylthiouracil
03

Conditions

Graves' ophthalmopathy (TED)Graves' disease

Beyond the preview

Go deeper on NCT03066076.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03066076.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call